Factors associated with early graft dysfunction in cystic fibrosis patients receiving primary bilateral lung transplantation

European Journal of Cardio-thoracic Surgery

Volumn 41, Issue 3, 2012, Pages 686-690

  Felten, Marie Louise ^a   Sinaceur, Mériem ^b   Treilhaud, Michéle ^c   Roze, Hadrien ^d   Mornex, Jean François ^e   Pottecher, Julien ^f   Journois, Didier ^b   Fischler, Marc ^a  

^a FOCH HOSPITAL   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

^d BORDEAUX UNIVERSITY HOSPITAL   (France)

^e LOUIS PRADEL HOSPITAL   (France)

^f HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Cystic fibrosis; Lung transplantation; Primary graft dysfunction

Indexed keywords

LACTIC ACID; BIOLOGICAL MARKER; OXYGEN;

ADULT; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; FEMALE; FRANCE; HUMAN; ISCHEMIA; LACTATE BLOOD LEVEL; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POSTOPERATIVE PERIOD; PRIMARY GRAFT DYSFUNCTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; BLOOD; CLINICAL TRIAL; DONOR; GENERAL ANESTHESIA; HOSPITALIZATION; LUNG; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; PRESSURE; RISK FACTOR; STATISTICS; TIME; VASCULARIZATION;

ADULT; ANESTHESIA, GENERAL; BIOLOGICAL MARKERS; CYSTIC FIBROSIS; FEMALE; HUMANS; LACTIC ACID; LUNG; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; OXYGEN; PARTIAL PRESSURE; PRIMARY GRAFT DYSFUNCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TISSUE DONORS; WARM ISCHEMIA; YOUNG ADULT;

EID: 84861439496     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezr019     Document Type: Article

References (19)

1. Christie JD, Sager JS, Kimmel SE, Ahya VN, Gaughan C, Blumenthal NP et al. Impact of primary graft failure on outcomes following lung transplantation. Chest 2005;127:161-5.
2. Lee JC, Christie JD, Keshavjee S. Primary graft dysfunction: definition, risk factors, short- and long-term outcomes. Semin Respir Crit Care Med 2010;31:161-71.
3. Kuntz CL, Hadjiliadis D, Ahya VN, Kotloff RM, Pochettino A, Lewis J et al. Risk factors for early primary graft dysfunction after lung transplantation: a registry study. Clin Transplant 2009;23:819-30.
4. Christie JD, Edwards LB, Aurora P, Dobbels F, Kirk R, Rahmel AO et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report-2009. J Heart Lung Transplant 2009;28:1031-49.
5. Oto T, Levvey BJ, Whitford H, Griffiths AP, Kotsimbos T, Williams TJ et al. Feasibility and utility of a lung donor score: correlation with early posttransplant outcomes. Ann Thorac Surg 2007;83:257-63.
6. Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005;24:1454-9.
7. Prekker ME, Nath DS, Walker AR, Johnson AC, Hertz MI, Herrington CS et al. Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation. J Heart Lung Transplant 2006;25:371-8.
8. Maillet JM, Le Besnerais P, Cantoni M, Nataf P, Ruffenach A, Lessana A et al. Frequency, risk factors, and outcome of hyperlactatemia after cardiac surgery. Chest 2003;123:1361-6.
9. Lee JC, Christie JD. Primary graft dysfunction. Proc Am Thorac Soc 2009; 6:39-46.
10. Christie JD, Kotloff RM, Pochettino A, Arcasoy SM, Rosengard BR, Landis JR et al. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003;124:1232-41.
11. Thabut G, Mal H, Cerrina J, Dartevelle P, Dromer C, Velly JF et al. Graft ischemic time and outcome of lung transplantation: a multicenter analysis. Am J Respir Crit Care Med 2005;171:786-91.
12. Whitson BA, Nath DS, Johnson AC, Walker AR, Prekker ME, Radosevich DM et al. Risk factors for primary graft dysfunction after lung transplantation. J Thorac Cardiovasc Surg 2006;131:73-80.
13. Thabut G, Vinatier I, Stern JB, Leseche G, Loirat P, Fournier M et al. Primary graft failure following lung transplantation: predictive factors of mortality. Chest 2002;121:1876-82.
14. Prekker ME, Herrington CS, Hertz MI, Radosevich DM, Dahlberg PS. Early trends in PaO(2)/fraction of inspired oxygen ratio predict outcome in lung transplant recipients with severe primary graft dysfunction. Chest 2007;132:991-7.
15. Oto T, Levvey BJ, Snell GI. Potential refinements of the International Society for Heart and Lung Transplantation primary graft dysfunction grading system. J Heart Lung Transplant 2007;26:431-6.
16. Bharat A, Saini D, Steward N, Hachem R, Trulock EP, Patterson GA et al. Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection. Ann Thorac Surg 2010;90: 1094-101.
17. Meachery G, De Soyza A, Nicholson A, Parry G, Hasan A, Tocewicz K et al. Outcomes of lung transplantation for cystic fibrosis in a large UK cohort. Thorax 2008;63:725-31.
18. Inci I, Stanimirov O, Benden C, Kestenholz P, Hofer M, Boehler A et al. Lung transplantation for cystic fibrosis: a single center experience of 100 consecutive cases. Eur J Cardiothorac Surg 2012;41:435-40.
19. Scientific Registry of Transplant Recipients, http://www.srtr.org/default.aspx, 2010 (28 July 2010, date last accessed).